Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2024-2032

Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A3385
Buy Now

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Lymphoma Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Hodgkin Lymphoma
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Non-Hodgkin Lymphoma
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Test Type
    7.1    Chemotherapy
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Radiation Therapy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunotherapy
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Targeted Therapy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Biologic Therapy
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8   Market Breakup by Drug
    8.1    Adcetris
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Rituxan
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Opdivo
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Imbruvica
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Keytruda
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Revlimid
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
            9.1.1.1 Market Trends
            9.1.1.2 Market Forecast
        9.1.2 Canada
            9.1.2.1 Market Trends
            9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
            9.2.1.1 Market Trends
            9.2.1.2 Market Forecast
        9.2.2 Japan
            9.2.2.1 Market Trends
            9.2.2.2 Market Forecast
        9.2.3 India
            9.2.3.1 Market Trends
            9.2.3.2 Market Forecast
        9.2.4 South Korea
            9.2.4.1 Market Trends
            9.2.4.2 Market Forecast
        9.2.5 Australia
            9.2.5.1 Market Trends
            9.2.5.2 Market Forecast
        9.2.6 Indonesia
            9.2.6.1 Market Trends
            9.2.6.2 Market Forecast
        9.2.7 Others
            9.2.7.1 Market Trends
            9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
            9.3.1.1 Market Trends
            9.3.1.2 Market Forecast
        9.3.2 France
            9.3.2.1 Market Trends
            9.3.2.2 Market Forecast
        9.3.3 United Kingdom
            9.3.3.1 Market Trends
            9.3.3.2 Market Forecast
        9.3.4 Italy
            9.3.4.1 Market Trends
            9.3.4.2 Market Forecast
        9.3.5 Spain
            9.3.5.1 Market Trends
            9.3.5.2 Market Forecast
        9.3.6 Russia
            9.3.6.1 Market Trends
            9.3.6.2 Market Forecast
        9.3.7 Others
            9.3.7.1 Market Trends
            9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
            9.4.1.1 Market Trends
            9.4.1.2 Market Forecast
        9.4.2 Mexico
            9.4.2.1 Market Trends
            9.4.2.2 Market Forecast
        9.4.3 Others
            9.4.3.1 Market Trends
            9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
            14.3.1.1 Company Overview
            14.3.1.2 Product Portfolio
            14.3.1.3 Financials
            14.3.1.4 SWOT Analysis
        14.3.2    Bristol-Myers Squibb Company
            14.3.2.1 Company Overview
            14.3.2.2 Product Portfolio
            14.3.2.3 Financials
            14.3.2.4 SWOT Analysis
        14.3.3    Eli Lilly and Company
            14.3.3.1 Company Overview
            14.3.3.2 Product Portfolio
            14.3.3.3 Financials
            14.3.3.4 SWOT Analysis
        14.3.4    F. Hoffmann-La Roche Ltd.
            14.3.4.1 Company Overview
            14.3.4.2 Product Portfolio
            14.3.4.3 SWOT Analysis
        14.3.5    Johnson & Johnson Services, Inc.
            14.3.5.1 Company Overview
            14.3.5.2 Product Portfolio
            14.3.5.3 Financials
            14.3.5.4 SWOT Analysis
        14.3.6    Merck & Co. Inc.
            14.3.6.1 Company Overview
            14.3.6.2 Product Portfolio
            14.3.6.3 Financials
            14.3.6.4 SWOT Analysis
        14.3.7    Novartis International AG
            14.3.7.1 Company Overview
            14.3.7.2 Product Portfolio
            14.3.7.3 Financials
            14.3.7.4 SWOT Analysis
        14.3.8    Spectrum Pharmaceuticals, Inc.
            14.3.8.1 Company Overview
            14.3.8.2 Product Portfolio
            14.3.8.3 Financials
            14.3.8.4 SWOT Analysis
        14.3.9    Takeda Pharmaceutical Company Ltd.
            14.3.9.1 Company Overview
            14.3.9.2 Product Portfolio
            14.3.9.3 Financials
            14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
            14.3.10.1 Company Overview
            14.3.10.2 Product Portfolio
            14.3.10.3 Financials
            14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Lymphoma Treatment Market: Major Drivers and Challenges
Figure 2: Global: Lymphoma Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Lymphoma Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Lymphoma Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Lymphoma Treatment Market: Breakup by Test Type (in %), 2023
Figure 6: Global: Lymphoma Treatment Market: Breakup by Drug (in %), 2023
Figure 7: Global: Lymphoma Treatment Market: Breakup by Region (in %), 2023
Figure 8: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Lymphoma Treatment (Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Lymphoma Treatment (Non-Hodgkin Lymphoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Lymphoma Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Lymphoma Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Lymphoma Treatment (Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Lymphoma Treatment (Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Lymphoma Treatment (Immunotherapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Lymphoma Treatment (Immunotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Lymphoma Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Lymphoma Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Lymphoma Treatment (Biologic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Lymphoma Treatment (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Lymphoma Treatment (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Lymphoma Treatment (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Lymphoma Treatment (Adcetris) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Lymphoma Treatment (Adcetris) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Lymphoma Treatment (Rituxan) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Lymphoma Treatment (Rituxan) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Lymphoma Treatment (Opdivo) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Lymphoma Treatment (Opdivo) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Lymphoma Treatment (Imbruvica) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Lymphoma Treatment (Imbruvica) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Lymphoma Treatment (Keytruda) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Lymphoma Treatment (Keytruda) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Lymphoma Treatment (Revlimid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Lymphoma Treatment (Revlimid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Lymphoma Treatment (Other Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Lymphoma Treatment (Other Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia-Pacific: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia-Pacific: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Lymphoma Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Lymphoma Treatment Market: Breakup by Country (in %), 2023
Figure 86: Middle East and Africa: Lymphoma Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Lymphoma Treatment Industry: SWOT Analysis
Figure 88: Global: Lymphoma Treatment Industry: Value Chain Analysis
Figure 89: Global: Lymphoma Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Lymphoma Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Lymphoma Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Lymphoma Treatment Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
Table 4: Global: Lymphoma Treatment Market Forecast: Breakup by Drug (in Million US$), 2024-2032
Table 5: Global: Lymphoma Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Lymphoma Treatment Market: Competitive Structure
Table 7: Global: Lymphoma Treatment Market: Key Players

Lymphoma Treatment Market Report by Type (Hodgkin Lymphoma, Non-Hodgkin Lymphoma), Test Type (Chemotherapy, Radiation Therapy, Immunotherapy, Targeted Therapy, Biologic Therapy, and Others), Drug (Adcetris, Rituxan, Opdivo, Imbruvica, Keytruda, Revlimid, and Others), and Region 2024-2032
Purchase options




Inquire Before BuyingInquire Before Buying
Speak to an AnalystSpeak to an Analyst     
Request BrochureRequest Brochure         
Request CustomizationRequest Customization
Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More

Services

Industries

Industries

Quick Links

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

Competitive Intelligence and Benchmarking Consumer Surveys and Feedback Reports Market Entry and Opportunity Assessment Pricing and Cost Research Procurement Research Report Store
Aerospace and Defense Agriculture Automotive BFSI Chemicals and Materials Construction and Manufacturing Electronics and Semiconductors Energy and Mining Food and Beverages Healthcare Packaging Retail Technology and Media Transportation and Logistics
Media Room Blogs Press Releases Our Customers Become a Publisher FAQ's

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70 , Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

© Copyright IMARC Services Private Limited 2024. All rights reserved. Terms & Conditions | Privacy Policy | SiteMap